Get access to our best features
Get access to our best features
Published 1 year ago

Therapeutic-dose anticoagulation may improve COVID-19 outcomes for noncritical inpatients – Healio

Summary by Ground News
A therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19. The FREEDOM COVID trial ultimately did not meet its primary endpoint, Valentin Fuster, MD, PhD, said during a late-breaking clinical trials presentation.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)